Mannkind (MNKD) Return on Capital Employed Growth (5y) (2016 - 2026)
Mannkind (MNKD) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Mannkind | 1.25 Bn | 1.12 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,569.00 |
| Dec 31, 2025 | 17,669.00 |
| Sep 30, 2025 | -49,406.00 |
| Jun 30, 2025 | 17,163.00 |
| Mar 31, 2025 | 23,140.00 |
| Dec 31, 2024 | 17,568.00 |
| Sep 30, 2024 | 18,358.00 |
| Jun 30, 2024 | 38,529.00 |
| Mar 31, 2024 | 24,758.00 |
| Dec 31, 2023 | 594,316.00 |
| Sep 30, 2023 | -166,950.00 |
| Jun 30, 2023 | -82,257.00 |
| Mar 31, 2023 | -157,286.00 |
| Dec 31, 2022 | -66,208.00 |
| Sep 30, 2022 | -42,007.00 |
| Jun 30, 2022 | 150,803.00 |
| Mar 31, 2022 | -222,442.00 |
| Dec 31, 2021 | -72,490.00 |
| Sep 30, 2021 | 159,750.00 |
| Jun 30, 2021 | -21,685.00 |